Patient Guide: Study Assessing Long-term Safety and Efficacy of Alpelisib in Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Who Previously Participated in Study CBYL719F12002 (EPIK-P1)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 6 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04980833
Status: ACTIVE_NOT_RECRUITING
Condition: PIK3CA-related Overgrowth Spectrum (PROS)
Phase: PHASE2

Find a Study Location Near You

This study is available at 6 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Boston, Massachusetts
  • Dijon,
  • Montpellier,
  • • And 3 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily